Literature DB >> 9374472

Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells.

D Chauhan1, P Pandey, A Ogata, G Teoh, N Krett, R Halgren, S Rosen, D Kufe, S Kharbanda, K Anderson.   

Abstract

Cytochrome c is a mitochondrial protein that induces apoptosis when accumulated in the cytosol in response to diverse stress inducers. This protein has also been shown to cause apoptosis when added to cell free extracts. In this report, we studied the role of cytochrome c (cyto-c) in dexamethasone (Dex), anti-Fas monoclonal antibody (mAb), and ionizing radiation-induced apoptosis in multiple myeloma cells. The results demonstrate that ionizing radiation-induced apoptosis is associated with an increase in cytosolic cyto-c levels, whereas apoptosis induced by Dex or anti-Fas mAb has no detectable effect on cyto-c release. By contrast, caspase-3 was activated in response to all of these agents. Thus, our findings suggest that Dex or anti-Fas mAb-induced apoptosis is not accompanied by cyto-c release and that there are at least two different pathways leading to activation of caspases and induction of apoptosis in multiple myeloma cells that can be distinguished by accumulation of cytosolic cyto-c.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374472     DOI: 10.1074/jbc.272.48.29995

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway.

Authors:  P Erhardt; E J Schremser; G M Cooper
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Role for caspase-mediated cleavage of Rad51 in induction of apoptosis by DNA damage.

Authors:  Y Huang; S Nakada; T Ishiko; T Utsugisawa; R Datta; S Kharbanda; K Yoshida; R V Talanian; R Weichselbaum; D Kufe; Z M Yuan
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 3.  Cytochrome c: the Achilles' heel in apoptosis.

Authors:  A V Kulikov; E S Shilov; I A Mufazalov; V Gogvadze; S A Nedospasov; B Zhivotovsky
Journal:  Cell Mol Life Sci       Date:  2011-12-17       Impact factor: 9.261

4.  Gamma-tocopheryl quinone stimulates apoptosis in drug-sensitive and multidrug-resistant cancer cells.

Authors:  Kenneth H Jones; Jennifer J Liu; Jennifer S Roehm; Jason J Eckel; Tobin T Eckel; Chad R Stickrath; Craig A Triola; Zongcheng Jiang; Gianna M Bartoli; David G Cornwell
Journal:  Lipids       Date:  2002-02       Impact factor: 1.880

5.  Proteomic analysis identifies mechanism(s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13.

Authors:  Dharminder Chauhan; Kenneth C Anderson; Ting Du; Yan Song; Arghya Ray
Journal:  Leukemia       Date:  2020-05-18       Impact factor: 11.528

6.  Uncouplers of oxidative phosphorylation can enhance a Fas death signal.

Authors:  G Linsinger; S Wilhelm; H Wagner; G Häcker
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

7.  Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).

Authors:  Klaus Podar; Marc S Raab; Jing Zhang; Douglas McMillin; Iris Breitkreutz; Yu-Tzu Tai; Boris K Lin; Nikhil Munshi; Teru Hideshima; Dharminder Chauhan; Kenneth C Anderson
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

8.  Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis.

Authors:  A D Tepper; E de Vries; W J van Blitterswijk; J Borst
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 9.  Preclinical studies of novel targeted therapies.

Authors:  Teru Hideshima; Kenneth C Anderson
Journal:  Hematol Oncol Clin North Am       Date:  2007-12       Impact factor: 3.722

Review 10.  Role of Apo2L/TRAIL and Bcl-2-family proteins in apoptosis of multiple myeloma.

Authors:  Quan Chen; Subrata Ray; Mohamad A Hussein; Gordan Srkalovic; Alexandru Almasan
Journal:  Leuk Lymphoma       Date:  2003-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.